The Haystack Project
  • Home
  • About Us Participants Partners Board and Advisors
  • Priorities
  • PROTECT Rare
  • Rare Disease Approvals HEART Act
  • Speaker Series Payer Engagement Health Equity Rare Cancer
  • Inflation Reduction Act Medicare Section 340b Medicaid FDA ICER
  • Patient Stories
  • Join
  • Take Action
The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Blue-Banner.png
The Haystack Project

Resources

The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
March 03, 2023

POV Report - Choroideremia→

March 03, 2023/ Michelle Osburn

Read more.

March 03, 2023/ Michelle Osburn/ /Source
Reports
Choroideremia, other issues, ICER, advocacy

Michelle Osburn

June 14, 2022

Press Release: Haystack Project Applauds the Inclusion of the HEART Act in the User Fee Package→

June 14, 2022/ Michelle Osburn

Read more.

June 14, 2022/ Michelle Osburn/ /Source
Reports
HEART Act, news

Michelle Osburn

January 10, 2022

Press Release: New Report for Uveal Melanoma Patients→

January 10, 2022/ Michelle Osburn

Read more.

January 10, 2022/ Michelle Osburn/ /Source
Reports
press release, news

Michelle Osburn

December 26, 2021

POV Report - Uveal Melanoma→

December 26, 2021/ Michelle Osburn

Read more.

December 26, 2021/ Michelle Osburn/ /Source
Reports
uveal melanoma, pov, other issues, ICER, advocacy

Michelle Osburn

January 10, 2021

About Health Equity in Access to Treatment (HEAT)→

January 10, 2021/ Rebecca Balliet

Read more.

January 10, 2021/ Rebecca Balliet/ /Source
Reports
heat

Rebecca Balliet

January 10, 2021

About the Advocacy Empowerment Institute→

January 10, 2021/ Rebecca Balliet

Read more.

January 10, 2021/ Rebecca Balliet/ /Source
Reports
AEI

Rebecca Balliet

December 31, 2019

Defining Value - For Us or With Us: Moving Us to Patient Oriented Value→

December 31, 2019/ Rebecca Balliet

Read more.

December 31, 2019/ Rebecca Balliet/ /Source
Presentations, Reports
ICER

Rebecca Balliet

August 06, 2017

Proposed adaptation of the ICER value framework for the assessment of treatments for ultra-rare conditions

August 06, 2017/ Rebecca Balliet
Proposed adaptation of the ICER value framework for the assessment of treatments for ultra-rare conditions

Explore the ICER value framework which presents a set of proposed adaptations to the ICER value assessment framework when the topic under review is a treatment for an “ultra-rare” condition. 

Read More
August 06, 2017/ Rebecca Balliet/
Reports
ICER

About Us

The Issues

Resources

News & Updates

© 2020 Haystack Project. All Rights Reserved. 

 

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.